<DOC>
	<DOCNO>NCT01317615</DOCNO>
	<brief_summary>This multi-centric , open-label study evaluate efficacy safety RAD001 patient advance ( stage IV ) Lung Cancer ( Large Cell ) neuroendocrine differentiation treat combination RAD001 paclitaxel carboplatin .</brief_summary>
	<brief_title>RAD001 With Paclitaxel Carboplatin First Line Treatment Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Carcinoma , Large Cell</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>1 . Patients give write informed consent obtain accord local guideline 2 . Histologically confirm diagnosis stage IV lung cancer LCNEC type accord WHO classification : 1 . Histolocial analysis newly diagnose disease must older 8 week sign consent 2 . Relapse must confirm histology 3 . Neuroendocrine differentiation 3 . World Health organisation ( WHO ) performance status grade ≤ 1 4. measurable disease 5 . Adequate bone marrow function 6 . Adequate liver function 7 . Adequate renal function 1 . History clinical evidence central nervous system ( CNS ) metastases . 2 . Presence SCLC cell 3 . Patients history another primary malignancy ≤ 3 year , exception inactive basal squamous cell carcinoma skin cervical cancer situ , early stage breast cancer ( LCIS DCIS ) prostate cancer ( stage T1a ) 4. prior chemotherapy treatment advance lung cancer and/or recover side effect therapy ( adjuvant treatment earlier stage IIII allow finish least one year study entry ) 5 . Patients receive investigational drug ≤ 28 day start study treatment recover side effect therapy 6 . Patients recover side effect major surgery patient may require major surgery course study 7 . Patients receive prior therapy RAD001 mTOR inhibitor 8 . Having severe and/or uncontrolled medical condition 9 . Women pregnant breast feed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Large cell carcinoma ,</keyword>
	<keyword>Lung cancer ,</keyword>
	<keyword>Neuroendocrine Tumors ,</keyword>
	<keyword>RAD001</keyword>
</DOC>